Asia Pacific Cardiac Pacemaker Market |Asia Pacific Cardiac Pacemaker Market size

1
Asia Pacific Cardiac Pacemaker Market Report
2019- Ken Research
2

• Globally, cardiovascular device industry has been
  growing at a significant rate, due to rising
  incidences of heart diseases and other
  cardiovascular disorders. Over the years,
  technological advancements and growing awareness
  have boosted the growth of cardiovascular devices
  market. The rising prevalence of the diseases
  forms one of the major factors driving the growth
  of the cardiac pacemaker market.

3

• The global market for cardiac pacemaker is
  growing at a rapid pace with huge amount of
  resources being invested in prevention, proper
  diagnosis and treatment of cardiac disorders.
  Globally, discovery and development of effective
  pacemaker is the key focus of many pharmaceutical
  giants. Global cardiac pace-makers market has
  been witnessing rapid and healthy growth rate,
  particularly in the developed economies, due to
  technological improvements and emergence of new
  market players.

4

• The market has exhibited a positive growth rate
  over the past few years due to continuous
  development of cardiac devices which has opened
  new opportunities in the health care industry.In
  terms of geography, North America accounted for
  major share of the total market followed by
  Europe and Asia. In 2014, North America accounted
  for , whereas Europe accounted for and rest
  was covered by Asia Pacific.

5

• However, with recent development in technology
  and increased research and development, the focus
  of cardiac pacemaker and its effectives in terms
  of enhanced life longevity has shifted towards
  therapeutics. In 2014, the global cardiac
  pacemaker market has reached USD million,
  registering a growth of 10.9 from previous year

6

• The Asia-Pacific cardiac pacemaker market is
  growing at a rapid pace with huge amount of
  resources being invested in prevention, proper
  diagnosis and treatment of cancer. In Asia,
  cardiac disorder has become the main cause of
  deaths and almost half of worlds cancer deaths
  occur in Asia. The high incidence of cardiac
  death rates in Asia can be accounted to heavy
  pollution, changing age structure, westernized
  diets and lifestyles and others. The revenue
  generated in the Asia cardiac pacemaker market
  has grown from USD Million in 2009 to USD
  million in 2014 at a CAGR of .

7

• The cardiac pacemaker market has also faced
  numerous challenges in terms of increased
  competition because of rising number of organized
  and unorganized player in the market thus leading
  to competition in terms of price and thus
  negatively affecting the revenue. In terms of
  geography, Japan captured the largest share in
  the market around accounting to USD million
  in 2014. India registered second largest share of
  of the Asia cardiac pacemaker market in 2014,
  amounting to USD million. Additionally, China
  captured of the market in 2014.

8

• Cardiac disorder is a complex disease that can
  affect different people in different ways. Future
  cardiac treatments will rely on the choice of the
  most appropriate combination of treatments for
  patients, based on the genetic profile of their
  disorders. The market in the Asia is expected to
  get intensified further because domestic players
  in different countries have been increasing their
  research and development expenditure in order to
  reduce per unit cost of production and compete
  with global players in terms of price levels and
  products offered.

9

• Overall, it is predicted that the value of
  cardiac pacemaker market in Asia-Pacific region
  will incline to USD million in 2019 from USD
  million in 2014. Greater influx of patients in
  cardiac care centres due to rising awareness
  among the people about the right place for best
  treatment will continue to escalate the growth of
  cardiac treatment in the region. The incidences
  of cardiovascular diseases in India have been on
  a steady rise since the past decade.

10

• These diseases comprise a major portion of
  non-communicable diseases and have been the major
  cause of deaths in the world, accounting for more
  than a third of the total number of deaths. In
  India, the sales of cardiac pacemaker registered
  a CAGR of during 2009-2014. In 2009, market
  revenue stood at INR million which grew to INR
  million in 2014. The rise in revenue can be
  attributed to emergence of new and effective
  pacemakers in the market, rising awareness and
  others. A major factor that has contributed to
  such a stupendous growth of this market is
  advances in technologies.

11

• The cardiac pacemaker market in China has
  observed a major proportion covered by global
  pharmaceutical companies and a minute proportion
  dominated by local pharmaceutical companies.
  Overtime, Chinas cardiac pacemaker market has
  transformed itself to renowned as the largest
  segment in the pharmaceutical market of China.The
  pacemaker market has generated revenues worth USD
  million in 2009 which grew at rate of 20.0 and
  reached USD million in 2011. The China
  pacemaker market revenues have increased at a
  CAGR of over the period of 5 years from
  2009-2014.

12

• A major factor contributing to the growth of this
  market is the growth of ageing population in the
  China which has a greater susceptibility to
  cardiac disorders, thus leading to an increase in
  number of cardiac cases. The challenge in this
  sector is to maintain links and tie-ups with
  doctors and hospitals and overcome trust issues
  which are highly prevalent among the customers
  development and launch of new drugs in the
  market. In terms of implantability, the internal
  pacemakers capture major proportion of the
  market, contributing towards of the total
  pacemaker market revenue in 2014, amounting for
  USD million.

13

• External pacemakers on the other hand accounted
  for of the total market, amounting for USD
  million of total pacemaker sales in 2014 In 2014,
  single chambered pacemakers captured share of
  the market, accounting for USD million, whereas
  double chambered contributed towards of
  revenue generated by the pacemaker market,
  amounting to USD million in 2014. The share of
  global cardiac pacemaker manufacturing companies
  was recorded at 98.0 in 2014 which amounted to
  USD million.

14

• In Japan the high incidence of cardiac disease
  rates can be accounted to heavy pollution,
  changing age structure, transformation towards
  westernized cultures, increasing consumption of
  tobacco, rising incidence of smoking and others.
  Japan's ageing and affluent population represents
  strong opportunities for pacemaker manufacturers
  The sales of cardiac pacemakers were registered
  as USD million in 2009 which grew at a CAGR of
  to reach USD million in 2014.

15

• Source https//www.kenresearch.com/healthcare/med
  ical-devices/asia-pacific-cardiac-pacemaker-resear
  ch-report/655-91.html
•  Contact Ken ResearchAnkur
  Gupta, Head Marketing CommunicationsAnkur_at_kenre
  search.com91-9015378249
• Website www.kenresearch.com

16
Thank you